Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial
Asadirad et al., Phytotherapy Research, doi:10.1002/ptr.7375
https://c19early.org/asadirad.html